Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QVAR in Premature Infants With BPD
NCT01373008Phase 2Unknown
- Sponsor
- Bnai Zion Medical Center
- Start
- Jun 2011
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in bronchopulmonary dysplasia (BPD) comparing Inhaled QVAR with Inhaled placebo (2 arms). Primary endpoint: Rate of readmissions to the hospital for BPD exacerbation at 4 months. Status: unknown.
02
Drugs
beclomethasone dipropionate
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT01373008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01373008.